Catalent Stock Jumps on $16.5 Billion Sale to Controlling Shareholder of Ozempic Maker Novo Nordisk
Published
Published
CTLT stock is up with heavy trading on the news Catalent (NYSE:CTLT) stock is climbing higher on Monday after the company agreed to..